Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.

Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
The Journal of Immunology (Impact Factor: 5.36). 08/1999; 163(2):913-9.
Source: PubMed

ABSTRACT Recent publications have provided confusing information on the importance of the J chain for secretion of dimeric IgA at mucosal surfaces. Using J chain-deficient (J chain-/-) mice, we addressed whether a lack of J chain had any functional consequence for the ability to resist challenge with cholera toxin (CT) in intestinal loops. J chain-/- mice had normal levels of IgA plasma cells in the gut mucosa, and the Peyer's patches exhibited normal IgA B cell differentiation and germinal center reactions. The total IgA levels in gut lavage were reduced by roughly 90% as compared with that in wild-type controls, while concomitantly serum IgA levels were significantly increased. Total serum IgM levels were depressed, whereas IgG concentrations were normal. Following oral immunizations with CT, J chain-/- mice developed 10-fold increased serum antitoxin IgA titers, but gut lavage anti-CT IgA levels were substantially reduced. However, anti-CT IgA spot-forming cell frequencies in the gut lamina propria were normal. Anti-CT IgM concentrations were low in serum and gut lavage, whereas anti-CT IgG titers were unaltered. Challenge of small intestinal ligated loops with CT caused dramatic fluid accumulation in immunized J chain-/- mice, and only 20% protection was detected compared with unimmunized controls. In contrast, wild-type mice demonstrated 80% protection against CT challenge. Mice heterozygous for the J chain deletion exhibited intermediate gut lavage anti-CT IgA and intestinal protection levels, arguing for a J chain gene-dosage effect on the transport of secretory IgA. This study unequivocally demonstrates a direct relationship between mucosal transport of secretory SIgA and intestinal immune protection.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bacterial and viral infections of the gastrointestinal tract are more common in the elderly and represent a major cause of morbidity and mortality. The mucosal immune system provides the first line of defence against pathogens acquired by ingestion and inhalation, but its function is adversely affected in the elderly. This aging-related decline in the immune function is termed immunosenescence and is associated with diminished abilities to generate protective immunity, reduced vaccine efficacy, increased incidence of cancer, inflammation and autoimmunity, and the impaired ability to generate tolerance to harmless antigens. In this review we describe our current understanding of the effects immunosenescence has on the innate and adaptive arms of the mucosal immune system in the intestine. Current estimates suggest that by the year 2050 up to 40 % of the UK population will be over 65 years old, bringing with it important health challenges. A thorough understanding of the mechanisms that contribute to the development of immunosenescence is therefore crucial to help identify novel approaches to improve mucosal immunity in the elderly.
    Biogerontology 04/2014; 16(2). DOI:10.1007/s10522-014-9498-z · 3.01 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It is increasingly being appreciated that innate immune mechanisms play a key role for the tuning of adaptive immunity in the gut and main-tenance of mucosal homeostasis. Innate responses use preformed and rapidly synthesised effectors and sensors that lead to spontaneous acti-vation or modulation of cellular functions, aiming at elimination of mi-crobial challenges and return of the local tissue to a basal state with minimal pathology. Efficient adaptive immunity depends on postnatal 'education' of specific immune cells and induction of immunological memory in processes that are significantly modulated by innate immune responses. The intestinal immune system has through evolution devel-oped two layers of adaptive non-inflammatory defence: Immune exclu-sion provided by secretory antibodies to limit epithelial penetration and host invasion of microorganisms as well as other potentially dangerous antigens; and immunosuppressive mechanisms to inhibit overreaction against innocuous luminal antigens – often referred to collectively as 'oral tolerance'. Both these strategies depend on co-operation of adaptive immune mechanisms with the innate defence system, including crosstalk between the intestinal epithelium and various lamina propria cells. This review focuses on immunological mechanisms taking place at the epithelial level.


Available from